National Cancer System Characteristics and Global Pan-Cancer Outcomes
Edward Christopher Dee(Memorial Sloan Kettering Cancer Center), Paul L. Nguyen(Beth Israel Deaconess Medical Center), Fábio Ynoe de Moraes(Queen's University), Puneeth Iyengar(Memorial Sloan Kettering Cancer Center), Urvish Jain(University of Pittsburgh), Jenny Chen(Johns Hopkins University), Nancy Y. Lee(Memorial Sloan Kettering Cancer Center), Jonas Willmann(Memorial Sloan Kettering Cancer Center), Frederic Ivan L. Ting(University of St. La Salle), Frances Dominique V. Ho(University of the Philippines Manila), Bhav Jain(Stanford Medicine), Erin Jay G. Feliciano(Elmhurst Hospital Center), James Fan Wu(Medical College of Wisconsin)
Cited by 19
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|459